In the Pediatric AIDS Clinical Trials Group ( PACTG ) 230 protocol , infants were vaccinated with 4 doses of Chiron rgp120 with MF59 ( n = 48 ) , VaxGen rgp120 with aluminum hydroxide ( alum ; n = 49 ) , or placebo ( n = 19 ) between 0 and 20 weeks of age .